Posts in category

In Depth


Communication is key in navigating the pandemic, writes Angelo Pricolo If road rules and parking restrictions are a window into a society and its flexibility (see my recent column ‘La …

Pharmacy was getting bad press due to some convictions for supplying cocaine, while there was concern about out of date poisons legislation in the July 1920 edition of the Australasian …

Debbie Rigby takes a look at the latest in research news Interventions Delivered in the Community Pharmacy to Manage Allergic Rhinitis Pharmacists have a valuable role in the management of …

How is COVID-19 affecting the pharmacy sales market? Natalie Sirianni provides an update on the situation Firstly, I would like to say a big thank you to all pharmacists for …

The way pharmacists have been regulated, the punishments they experienced and the types of offences involved have changed over time. David Newgreen reports on his survey of reported prosecutions of …

Some pharmacies are almost in lockdown while others are barely acknowledging COVID-19 at all… this inconsistency confuses the public, writes Karalyn Huxhagen SA Health this week announced COVID testing in …

No matter how small you are, technology makes you mighty, writes Megan Kazantzis E-prescribing is one of the largest and most significant changes the industry has experienced since the computerisation …

We speak with the newly elected 2020/21 NAPSA president 1. How do you feel having been elected as the newest NAPSA president? It is a great honour and privilege to …

Debbie Rigby takes a look at the latest in research news Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia A systematic review and network meta-analysis of 209 studies explored …

Things won’t return to the old ‘normal’, so pharmacies have to innovate and be clever to thrive as restrictions lift, say Bruce Annabel and Mal Scrymgeour When the coronavirus potentially …

Medicines are intended to prevent and treat disease and illness. Yet, in many cases, particularly those involving older Australians, medicines may be doing more harm than good As masters of …

Biosimilars and the pharmacist’s role in their supply remains controversial, writes Carlene McMaugh Biological pharmaceutical products have been a part of the landscape of therapeutics for a number of years …